{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:50:30Z","timestamp":1769763030081,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"King Saud University, Deanship of Scientific Research, Research Group","award":["#RG-1438-018"],"award-info":[{"award-number":["#RG-1438-018"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.actatropica.2018.11.022","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T23:39:55Z","timestamp":1542929995000},"page":"193-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Efficacy of Montanide (IMS 3015) as an adjuvant for an inactivated Rift Valley fever (RVF) vaccine in sheep"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5322-3860","authenticated-orcid":false,"given":"Mohamed A.","family":"Hussein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haytham A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahgat A.","family":"Abd El-Rhman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timour N.","family":"Morcoss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0497-4908","authenticated-orcid":false,"given":"Ahmed Elsadek","family":"Fakhr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3247-5898","authenticated-orcid":false,"given":"Ayman Abdel Aziz","family":"Swelum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Alowaimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hammed A.","family":"Tukur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7633-730X","authenticated-orcid":false,"given":"Islam M.","family":"Saadeldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2018.11.022_bib0005","unstructured":"Abdel-Gaffar, S., Mohsen, A., Ayoub, N., El-Nimr, M., Fathia, M., 1979. Rift Valley fever in Egypt III. Diagnosis and vaccination. 14th Arab. Vet. Cong., 24-29 march Cairo, pp 1-11."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0010","series-title":"Trial for Production of Improved Inactivated RVFV Vaccine","author":"Abou-El-Fadl","year":"2007"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0015","series-title":"Studies on Preparation of Newly Oil Adjuvanted FMD Vaccine","author":"Ahmed","year":"2008"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0020","first-page":"237","article-title":"Comparative evaluation of the immune efficiency for FMD vaccines prepared with IMS 3013 and Aluminum hydroxide gel in Guinea pigs","volume":"64","author":"Ali","year":"2004","journal-title":"J. Egypt. Vet. Med. Assoc."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-0-12-039233-9.50013-5","article-title":"Immunomodifiers in vaccines","volume":"33","author":"Altman","year":"1989","journal-title":"Adv. Vet. Sci. Comp. Med."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0030","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0009-8981(81)90049-8","article-title":"The application of a sensitive uricase-peroxidase coupled reaction to a centrifugal fast analyser for the determination of uric acid","volume":"116","author":"Atriss","year":"1981","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0035","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1016\/S0264-410X(00)00498-9","article-title":"Adjuvants designed for veterinary and human vaccines","volume":"19","author":"Aucotuier","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0040","series-title":"Outline of Veterinary Clinical Pathology","first-page":"175","article-title":"Kidney function tests","author":"Benjamine","year":"1978"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0045","first-page":"895","article-title":"Immunological response of Egyptian fat-tail sheep to inactivated & live attenuated Smithburn RVF vaccine","volume":"55","author":"Botros","year":"1995","journal-title":"J. Egypt. Vet. Med. Ass."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/clinchem\/12.1.18","article-title":"Comparison of carbonate and uricase-carbonate methods for the determination of uric acid in serum","volume":"12","author":"Caraway","year":"1966","journal-title":"Clin. Chem."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0055","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0264-410X(96)00183-1","article-title":"Adjuvants, a classification and review of their mode of action","volume":"15","author":"Cox","year":"1997","journal-title":"Vaccine."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0060","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1016\/j.vaccine.2013.05.078","article-title":"Montanide ISA 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle","volume":"31","author":"Dara","year":"2013","journal-title":"Vaccine J."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006460","article-title":"Rift valley fever viral load correlates with the human inflammatory response and coagulation pathway abnormalities in humans with hemorrhagic manifestations","volume":"12","author":"de St Maurice","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0070","first-page":"135","article-title":"Improving of inactivated rift valley fever virus vaccine using montanide oil ISA 206 as an adjuvant","volume":"25","author":"El-Bagoury","year":"2013","journal-title":"Benha Vet. Med. J."},{"issue":"1997","key":"10.1016\/j.actatropica.2018.11.022_bib0075","first-page":"22","article-title":"Production and evaluation of RVF diagnostic antigens by ELISA technique. 3rd Arab Vet","author":"Elian","year":"1997","journal-title":"Med. Cong. March"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0080","series-title":"Vims Taxonomy. Classification and Nomenclature of Viruses. Seventh Report of the International Committee on Taxonomy of Viruses.","first-page":"614","article-title":"Family Bmiyaviridae","author":"Elliott","year":"2000"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0085","series-title":"Microbiology","article-title":"Studies on the inactivated vaccine against Rift Valley Fever","author":"El-Nimr","year":"1980"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0090","first-page":"363","article-title":"Clinical and laboratory studies on Rift Valley Fever Vaccines in sheep","volume":"57","author":"El- Sawalhy","year":"1997","journal-title":"J. Egypt. Vet. Med. Ass."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0095","series-title":"Studies on Rift Valley Fever Vaccine Inactivated With Binary","author":"Eman","year":"1995"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0100","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0019-2791(71)90454-X","article-title":"Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G","volume":"8","author":"Engvall","year":"1971","journal-title":"Immunochemistry"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/vaccines5030029","article-title":"Current status of rift valley fever vaccine development","volume":"5","author":"Faburay","year":"2017","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0110","first-page":"949","article-title":"Comparative studies on serological response of locally produced live attenuated and inactivated Rift Valley vaccines","volume":"57","author":"Gihan","year":"1997","journal-title":"J. Egypt. Vet. Med. Ass."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0115","first-page":"362","article-title":"Studies on liver function in cattle vaccinated with Rinderpest and Rift Valley vaccines","volume":"53","author":"Gihan","year":"1993","journal-title":"J. Egypt. Vet. Med. Ass."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024135","article-title":"Rapid titration of measles and other viruses: optimization with determination of replication cycle length","volume":"6","author":"Grigorov","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-409X(98)00008-8","article-title":"Aluminum compounds as vaccine adjuvants","volume":"32","author":"Gupta","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.actatropica.2011.04.018","article-title":"Virus isolation sand high population density implicate Culex antennatus (Becker) (Diptera: culicidae) as a vector of Rift Valley Fever virus during an outbreak in the Nile Delta of Egypt","volume":"119","author":"Hanafi","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0135","series-title":"Improvement and Evaluation of Inactivated Rift Valley Fever Vaccine","author":"Ibrahim","year":"2002"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0140","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.14202\/vetworld.2015.1189-1198","article-title":"Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine","volume":"8","author":"Ibrahim","year":"2015","journal-title":"Vet. World"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0145","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/14760584.2017.1321482","article-title":"Rift Valley Fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate","volume":"16","author":"Ikegami","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/v3050493","article-title":"The pathogenesis of Rift Valley fever","volume":"3","author":"Ikegami","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0155","first-page":"417","article-title":"A preliminary report on an epidemic of Rift Valley fever in Egypt","volume":"52","author":"Imam","year":"2011","journal-title":"J. Egypt. Public Health Assoc."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0160","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/jmedent\/37.3.467","article-title":"Experimental detection of Rift Valley Fever virus by reverse transcription-polymerase chain reaction assay in large samples of mosquitoes","volume":"37","author":"Jupp","year":"2000","journal-title":"J. Med. Entomol."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0165","series-title":"Clinical Biochemistry of Domestic Animal","author":"Kaneko","year":"2008"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0170","series-title":"Some Studies on RVFV","author":"Karim","year":"1998"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0175","first-page":"532","article-title":"The determination of human serum albumin by its specific binding of anionic dye (3c4-Hydroxy benzenazo-benzoic acid)","volume":"12","author":"Kind","year":"1954","journal-title":"Clin. Chem. Acta."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0180","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural protein during the assembly of the head of Bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0185","first-page":"530","article-title":"Studies on immunodynamic purification and electron microscopy of pantropic Rift Valley Fever virus","volume":"20","author":"Lily","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0190","first-page":"719","article-title":"Studies of different adjuvants on the immune response of sheep to Rift Valley fever inactivated vaccine","volume":"64","author":"Marcoss","year":"1998","journal-title":"Vet. Med. J. Giza"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0195","first-page":"265","article-title":"Trails for production of highly immunized oily inactivated RVFV vaccine","volume":"5\u20136","author":"Mona","year":"2005","journal-title":"J. Egypt. Public Health Ass."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0200","first-page":"76","article-title":"Evaluation of immune response in Egyptian Balady sheep vaccinated with attenuated RVF and PPR vaccines","volume":"38","author":"Mouaz","year":"1998","journal-title":"Assuit Vet. Med. J."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0205","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0009-8981(65)90168-3","article-title":"The determination of human serum albumin by its specific binding of anionic dye (3c4-Hydroxy benzenazo-benzoic acid)","volume":"12","author":"Ness","year":"1965","journal-title":"Clin. Chem. Acta."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1357-4310(96)10058-7","article-title":"Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles","volume":"3","author":"O\u2019Hagan","year":"1997","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0215","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.provac.2009.07.026","article-title":"Adjuvant formulation for veterinary vaccines: montanide\u2122 Gel safety profile","volume":"1","author":"Parker","year":"2009","journal-title":"Proc Vaccinol."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0220","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0166-0934(03)00228-3","article-title":"IgG. Sandwich and IgM Capture enzyme Linked immunosorbent assay for the detection of antibody to Rift valley fever virus in domestic ruminants","volume":"113","author":"Paweska","year":"2003","journal-title":"J. Virol. Method."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0225","series-title":"Using Montanide (IMS)","author":"Ragaa","year":"2007"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0230","first-page":"493","article-title":"A simple method for estimating 50 percent end point","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0235","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ajcp\/28.1.56","article-title":"A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases","volume":"28","author":"Reitman","year":"1957","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0240","first-page":"4827","article-title":"Evaluation of soluble tetrazolium \/ Formazan Assay for cell growth and drug sensitivity in culture using human and other tumor cell lines","volume":"48","author":"Scudiero","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0245","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3201\/eid0812.020195","article-title":"Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000-01","volume":"8","author":"Shoemaker","year":"2002","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0250","doi-asserted-by":"crossref","first-page":"e0006474","DOI":"10.1371\/journal.pntd.0006474","article-title":"Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates","volume":"12","author":"Smith","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0255","first-page":"1","article-title":"Rift valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine","volume":"1","author":"Smithburn","year":"1949","journal-title":"Brit. J. Exp. Pathol."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0260","series-title":"Comparative Studies on Immune Response of FMD and RVF Combined Vaccine Containing OIMS 1313 Oil Adjuvant","author":"Sonia","year":"2003"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0265","series-title":"Studies on Preparation of an Improved Foot and Mouth Disease Oil Vaccine","author":"Sonia","year":"2008"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0270","unstructured":"Swanepoel, R., Coetzer J.A., 1994. Rift Valley Fever infectious disease of livestock with special reference to South Africa, edited by J.A.W. Coetzer G.R., Thomson R.C. Tustin. Cape Town: Oxford University Press; pp: 688\u2013717."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0275","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0264-410X(91)90155-Y","article-title":"Vitamin E adjuvant formulations in mice","volume":"9","author":"Tengerdy","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0280","series-title":"Manual of Clinical Immunology.","first-page":"506","article-title":"Microplate enzyme immunoassays for the immunodiagnosis of virus infections","author":"Voller","year":"1976"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0285","series-title":"Rift Valley Fever Foreign Animal Disease; Prevention, Diagnosis and Control","first-page":"209","author":"Walker","year":"1975"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0290","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/ajcp\/16.3_ts.40","article-title":"An accurate and rapid method for the determination of proteins in small amount of serum and plasma","volume":"10","author":"Weichselbaum","year":"1946","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0295","series-title":"Communicable Disease Surveillance and Response (CSR)","article-title":"Rift valley fever in Egypt","author":"WHO","year":"2003"},{"key":"10.1016\/j.actatropica.2018.11.022_bib0300","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3201\/eid0802.010023","article-title":"An outbreak of rift valley fever in Northeastern Kenya, 1997-1998","volume":"8","author":"Woods","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.actatropica.2018.11.022_bib0305","series-title":"Evaluation of Attenuated Bovine Diarrhoea-mucosal Disease Vaccine in Cattle","author":"Zeidan","year":"1990"}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X18311501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X18311501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T20:29:24Z","timestamp":1605472164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X18311501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":61,"alternative-id":["S0001706X18311501"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2018.11.022","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Montanide (IMS 3015) as an adjuvant for an inactivated Rift Valley fever (RVF) vaccine in sheep","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2018.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}